BioLife Solutions is poised to benefit from the booming cell and gene therapy sector. Read more to see my investment strategy ...

US real GDP stands nearly 1.9% above estimated sustainable full-employment potential, which is typical of late-stage economic ...

There are a few key trends to look for if we want to identify the next multi-bagger. In a perfect world, we'd like ...

By Anne Higuera Reporting for West Seattle Blog Six years into the city’s efforts to have developers help meet the need for affordable housing, things aren’t turning out exactly as expected. Seattle’s ...

The Progress Singapore Party has launched its 78-page manifesto ahead of the upcoming General Election, outlining over 60 ...

The National Chairman, Forum of State Commissioners for Finance, Akin Oyebode, speaks to DANIEL AYANTOYE on the controversy surrounding the delay in the implementation of local government autonomyThe ...

In mid-March here, I (Tom Yeung) wrote about three stocks to sell on an escalating trade war. President Donald Trump was ratcheting his tariff rhetoric, so we highlighted three import-reliant firms to ...

Ireland is in the firing line as US Internal Revenue Service (IRS) zooms in on multinationals' transfer pricing arrangements ...

Amazon's stock has taken a decent hit since it reached its all-time high back in early February 2025right before it dropped its FY 2024 annual report. Since then, shares are down more than 15%, but to ...

We have always known that from an economic and legal perspective, these tariffs are crazy. We didn’t know they would be stupid, too.